Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Down 47.9% in March

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 541,500 shares, a decrease of 47.9% from the February 28th total of 1,039,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 5,415.0 days. Approximately 0.3% of the shares of the company are sold short.

Recordati Industria Chimica e Farmaceutica Stock Performance

Shares of RCDTF stock remained flat at $55.54 during trading hours on Tuesday. The stock's 50-day moving average is $55.54 and its 200 day moving average is $53.76. Recordati Industria Chimica e Farmaceutica has a 52 week low of $52.25 and a 52 week high of $52.25. The stock has a market capitalization of $11.46 billion, a P/E ratio of 27.77 and a beta of 0.30.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.